Koyfin Home > Directory > Health Care > Acorda Therapeutics > Levered Free Cash Flow (FCF)

Acorda Therapeutics Levered Free Cash Flow (FCF) Chart (ACOR)

Acorda Therapeutics annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2020.
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-11m a -140.82% increase of 16m year over year
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-104m a -37.48% increase of 39m year over year
  • Acorda Therapeutics Annual Levered Free Cash Flow (FCF) for 2019 was $-167m a 165.24% decrease of -276m from 2018
  • Acorda Therapeutics Annual Levered Free Cash Flow (FCF) for 2018 was $109m a 13.25% increase of 14m from 2017
  • Acorda Therapeutics Annual Levered Free Cash Flow (FCF) for 2017 was $94m a 15.75% increase of 15m from 2016
Other Cash Flow Metrics:
  • Acorda Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $78m a 23.00% increase of 18m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Levered Free Cash Flow (FCF) Data

06/2020$-11m
03/2020$-37m
12/2019$-28m
09/2019$-27m
06/2019$-31m
03/2019$-80m
12/2018$-5m
09/2018$60m
06/2018$31m
03/2018$22m

Annual ACOR Levered Free Cash Flow (FCF) Data

2019$-167m
2018$109m
2017$94m
2016$80m
2015$30m
2014$85m
2013$47m
2012$5m
2011$46m
2010$-26m